 | Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director
finance.yahoo.com - March 21 at 8:05 AM |
 | VERONA PHARMA P/S (VRNA) Expected to Announce Earnings of -$0.57 Per Share
www.americanbankingnews.com - March 6 at 7:16 PM |
| VERONA PHARMA P/S to Post Q1 2019 Earnings of ($0.38) Per Share, Wedbush Forecasts (VRNA)
www.americanbankingnews.com - March 4 at 1:13 AM |
| VERONA PHARMA P/S Expected to Post Q1 2019 Earnings of ($0.76) Per Share (VRNA)
www.americanbankingnews.com - March 4 at 1:13 AM |
| Jefferies Financial Group Weighs in on VERONA PHARMA P/S's Q1 2019 Earnings (VRNA)
www.americanbankingnews.com - March 4 at 1:13 AM |
| Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update
finance.yahoo.com - February 26 at 10:18 AM |
| Verona Pharma Works Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - February 1 at 9:59 AM |
| Verona Pharma Enters Oversold Territory
finance.yahoo.com - January 16 at 9:39 AM |
 | Verona Pharma's nebulized ensifentrine shows mixed results in pharmacology study
seekingalpha.com - January 14 at 9:15 AM |
| Verona Pharma Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - January 11 at 10:08 AM |
| Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554
finance.yahoo.com - January 9 at 9:52 AM |
 | Verona Pharma PLC American Depositary Share (VRNA)
www.zacks.com - January 4 at 4:47 PM |
 | Verona Pharma PLC ADR
www.barrons.com - December 18 at 4:34 PM |
 | Verona Pharma plc (VRNA) Commences Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
www.streetinsider.com - December 17 at 9:42 AM |
| Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
finance.yahoo.com - December 17 at 9:42 AM |
| Verona Pharma plc's (VRNA) CEO Jan-Anders Karlsson on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 9:37 AM |
| Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2018
finance.yahoo.com - November 6 at 9:35 AM |
 | Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on
www.nasdaq.com - October 31 at 9:44 AM |
| Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
finance.yahoo.com - October 31 at 9:44 AM |
| Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Pre
www.nasdaq.com - October 26 at 9:48 AM |
| Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference
finance.yahoo.com - October 26 at 9:48 AM |
| Verona Pharma to Host Investor & Analyst R&D Forum on October 12, 2018
finance.yahoo.com - September 27 at 9:33 AM |
| Verona Pharma to Present Expanded Dataset from RPL554 Phase 2b Clinical Trial in COPD at European Respiratory Society International Congress
finance.yahoo.com - September 12 at 9:19 AM |
| Verona Pharma Announces Publication of Key Paper on RPL554 in COPD in the European Respiratory Journal
finance.yahoo.com - September 6 at 9:59 AM |
| Verona Pharma plc : PDMR Dealing & Issue of Shares
finance.yahoo.com - August 10 at 9:43 AM |
| Verona Pharma plc's (VRNA) CEO Jan-Anders Karlsson on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 4:11 PM |
 | Verona Pharma plc to Host Earnings Call
www.baystreet.ca - August 7 at 9:56 AM |
| Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2018
finance.yahoo.com - August 7 at 9:56 AM |
| Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
finance.yahoo.com - August 1 at 11:24 AM |
| Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2018 and Provide Clinical Development Update
finance.yahoo.com - July 26 at 9:45 AM |
| Verona Pharma plc : Notice of Results
finance.yahoo.com - July 26 at 9:45 AM |
| Verona Pharma to Present at 2018 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - July 24 at 10:01 AM |
 | In New Jersey and 7 Other States, Democrats Fill Ranks of Challengers
www.nytimes.com - June 6 at 9:46 AM |
| Verona Pharma's Shelf Registration Statement declared effective by SEC
finance.yahoo.com - June 4 at 9:36 AM |
| Verona Pharma plc : Block Listing Update
finance.yahoo.com - May 31 at 9:56 AM |
| Verona Pharma to Present at Upcoming Investor Conferences
finance.yahoo.com - May 30 at 9:44 AM |
| Verona Pharma PLC (VRNA) Highlights Clinical Data on RPL554 as First-in-Class Treatment for COPD
www.streetinsider.com - May 22 at 9:27 AM |
| Verona Pharma to Present Clinical Trial Data of RPL554 for COPD Maintenance Treatment at American Thoracic Society 2018 International Conference
finance.yahoo.com - May 9 at 9:43 AM |
| Verona Pharma plc : Miscellaneous
finance.yahoo.com - May 9 at 9:43 AM |
| Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
finance.yahoo.com - May 8 at 9:36 AM |
| Verona Pharma to Present at Bio€quity Europe 2018
finance.yahoo.com - May 4 at 9:35 AM |
| Verona Pharma plc : Result of AGM
finance.yahoo.com - May 3 at 9:33 AM |
| Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018
finance.yahoo.com - May 2 at 9:36 AM |
| Verona Pharma Announces Departure of Chief Medical Officer
finance.yahoo.com - April 11 at 10:23 AM |
| The Zacks Analyst Blog Highlights: Verona, Squibb, Protagonist and Amgen
finance.yahoo.com - March 29 at 10:07 AM |
| Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD
finance.yahoo.com - March 26 at 10:11 AM |
| Verona Pharma to Present at Upcoming Healthcare Investor Conferences
finance.yahoo.com - March 15 at 9:37 AM |
| Grant of Options and RSUs and PDMR Dealings
finance.yahoo.com - March 9 at 10:20 AM |
| Verona Pharma plc : Grant of Options and RSUs and PDMR Dealings
finance.yahoo.com - March 9 at 10:20 AM |
| Verona Pharma plc : 1st Quarter Results
finance.yahoo.com - March 8 at 10:06 AM |
